GI Dynamics Inc (GID)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GI Dynamics Inc (GID) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014398
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GI Dynamics Inc (GI Dynamics) is a medical device company that develops and commercializes endoscopy instruments. The company’s product includes EndoBarrier, an endoscopically delivered device therapy that is designed to mimic the mechanisms of metabolic surgery- without altering the anatomy. Its EndoBarrier is used for the treatment of type 2 diabetes and obesity. GI Dynamics serves to health care providers, such as gastroenterologists, endocrinologists, and bariatric surgeons; and distributors of medical devices. The company markets its products through distributors in Australia, Europe, and the US. It operates through its office located in Europe and Australia. GI Dynamics is headquartered in Lexington, Massachusetts, the US.

GI Dynamics Inc (GID) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GI Dynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GI Dynamics Inc, Medical Devices Deals, 2011 to YTD 2017 9
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs 11
GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs 12
GI Dynamics Completes Private Placement Of Chess Depository Interests For US$31.2 Million 13
GI Dynamics Completes Second Tranche Of Private Placement Of Chess Depository Interests For US$17.8 Million 14
GI Dynamics Completes Rights Offering Of Chess Depository Interests For US$2.2 Million 15
GI Dynamics Completes Private Placement For US$38 Million 16
GI Dynamics Completes IPO Of CHESS Depository Interests For US$86 Million 17
GI Dynamics Completes Private Placement Of CHESS Depository Interests For US$21 Million 18
Debt Offering 20
GI Dynamics to Raise USD5 Million in Private Placement of 5% Notes 2018 20
GI Dynamics Inc – Key Competitors 21
GI Dynamics Inc – Key Employees 22
GI Dynamics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Jan 31, 2017: GI Dynamics: Quarterly Report – Quarter Ended 31 December 2016 24
Jul 28, 2016: GI Dynamics: Appendix 4C: Quarter ended 30 June 2016 25
Corporate Communications 26
Aug 23, 2017: GI Dynamics Appoints Juliet Thompson to Company’s Board of Directors 26
Aug 13, 2017: GI Dynamics Welcomes New Members to its Scientific Advisory Board 27
Jun 19, 2017: GI Dynamics Announces Additional Members to Its Scientific Advisory Board 28
Jun 02, 2017: GI Dynamics Announces Change to Board of Directors 29
May 08, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier 30
Mar 13, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier 31
Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company’s Board of Directors 32
May 05, 2016: GI Dynamics Appoints Chief Financial Officer 33
May 03, 2016: GI Dynamics: Daniel J. Moore Elected Chairman of the Board 34
Mar 23, 2016: GI Dynamics Announces the Appointment of Medical Device Industry Veteran Scott Schorer as President & Chief Executive Officer 35
Other Significant Developments 36
Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
GI Dynamics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GI Dynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GI Dynamics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
GI Dynamics Inc, Medical Devices Deals, 2011 to YTD 2017 9
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs 11
GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs 12
GI Dynamics Completes Private Placement Of Chess Depository Interests For US$31.2 Million 13
GI Dynamics Completes Second Tranche Of Private Placement Of Chess Depository Interests For US$17.8 Million 14
GI Dynamics Completes Rights Offering Of Chess Depository Interests For US$2.2 Million 15
GI Dynamics Completes Private Placement For US$38 Million 16
GI Dynamics Completes IPO Of CHESS Depository Interests For US$86 Million 17
GI Dynamics Completes Private Placement Of CHESS Depository Interests For US$21 Million 18
GI Dynamics to Raise USD5 Million in Private Placement of 5% Notes 2018 20
GI Dynamics Inc, Key Competitors 21
GI Dynamics Inc, Key Employees 22
GI Dynamics Inc, Other Locations 23
GI Dynamics Inc, Subsidiaries 23

★海外企業調査レポート[GI Dynamics Inc (GID)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Synexus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • NIKE Inc:企業の戦略・SWOT・財務情報
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola v …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • IREN SpA (IRE):企業の財務・戦略的SWOT分析
    IREN SpA (IRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Health Care Service Corp:企業の戦略的SWOT分析
    Health Care Service Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Luxembourg Institute of Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Luxembourg Institute of Health (LIH), formerly Centre de Recherche Public de la Sante is a biomedical research organisation that offers pre-clinical and clinical research in the areas of biomedicine and healthcare. The organization offers research under various departments such as infection …
  • Ono Pharmaceutical Co Ltd (4528):製薬・医療:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Unum Therapeutics Inc (UMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …
  • RCS MediaGroup SpA (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup SpA (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genentech Inc-医療機器分野:企業M&A・提携分析
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that develops and markets medicines to address serious medical needs. Its clinical development pipeline includes alectinib and Erlotinib for metastatic non-small cell lung cancer; Anti-ST2 for ast …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Deutsche Biotech Innovativ AG (VUA):製薬・医療:M&Aディール及び事業提携情報
    Summary Deutsche Biotech Innovativ AG (DBI), formerly Venetus Beteiligungen AG, is a biotechnology company that develops drug candidates on indications sepsis and cancer. The company’s products comprise Adrecizumab, DB1RA and AB2302. It diagnostic based drug development approach and offers identific …
  • Daimler AG:企業の戦略・SWOT・財務情報
    Daimler AG - Strategy, SWOT and Corporate Finance Report Summary Daimler AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kansai Paint Co Ltd (4613):企業の財務・戦略的SWOT分析
    Kansai Paint Co Ltd (4613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • European Institute of Oncology-製薬・医療分野:企業M&A・提携分析
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Bank Of The Philippine Islands:企業の戦略・SWOT・財務分析
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • TVS Motor Co Ltd:企業の戦略・SWOT・財務情報
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆